Official Presentation of Live Cell Therapy Using Purtier Placenta | Stem Cell Malaysia
stemcellmalaysia.com Live cell therapy is a very effective stem cell therapy for improving health and even disease treatment other than for beauty and anti-aging. Purtier Placenta is a live cell therapy using deer placenta stem cells from New Zealand. Watch this official presentation for a complete understanding of live cell therapy with Purtier Placenta. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:0 0ratingsTime:08:59More inScience Technology

Read the rest here:
Official Presentation of Live Cell Therapy Using Purtier Placenta | Stem Cell Malaysia - Video

Stem Cell Therapy For Parkinsons Disease | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy for Parkinson #39;s Disease is still under research and study. However, there are impressive results by patients using oral placenta as stem cell therapy for their Parkinson #39;s disease. An 81 years old Asian with Stage 2 Parkinson #39;s disease observed cessation of tremor after only 4 weeks of oral placenta stem cell therapy. For more information on stem cell therapy, please visit Stem Cell Malaysia at stemcellmalaysia.comFrom:stemcells2012Views:118 2ratingsTime:11:49More inScience Technology

Read the rest here:
Stem Cell Therapy For Parkinsons Disease | Stem Cell Malaysia - Video

SAN DIEGO, CA--(Marketwire - Nov 19, 2012) - Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ) announced today that its wholly owned subsidiary, Regen BioPharma, Inc., has contracted Cascade Life Sciences, Inc. to research the safety and efficacy of Regen's HemaXellerate product usingmice models for testing.Cascade Life Sciences is a privately-owned San Diego-based company with a platform of stem cell related technologies that are being advanced to serve the research community and the commercial development of stem cell-based therapeutics. Sophia Khaldoyanidi, M.D., Ph.D. is the principal investigator of the study.

The results of Regen's study will provide the safety profile data required for filing of anInvestigational New Drug (IND) application for the product with the US Food and Drug Administration .Regen intends to file an IND Application in the fourth quarter of 2012 and conduct Phase I/II clinical trials during 2013 and 2014.

HemaXellerate offers the possibility of delivering a population of endothelial cells to restore blood production in patients with hematological conditions."Unlike current approaches of administering pharmaceuticals," said J. Christopher Mizer, President of Regen BioPharma, "our strategy is to heal the bone marrow by administering cells that provide the optimum mix of growth factors to stimulate the bone marrow into producing blood cells naturally."

Regen has submitted two provisional patent applications covering the use of different sources of endothelial cells to heal damaged bone marrow. These applications cover: (1) placental cells (61/648898 - Acceleration 0f Hematopoietic Reconstitution by Placental Endothelial and Endothelial Progenitor Cells); and (2) fat cells (61/670791 - Treatment of Hematopoietic Disorders).

About Bio-Matrix Scientific Group Inc. and Regen BioPharma, Inc.:

Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indications.

Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ), is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. To follow our development, visit us at http://www.regenbiopharma.com.

Disclaimer

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks

View original post here:
Bio-Matrix' Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate(TM) Cell Therapy

Princess Margaret Cancer Program will implement ComprehensiveBMT and Investigate Cell Therapy to continue leading role in cancer care and research

SALT LAKE CITY , Nov. 14, 2012 /CNW/ - Remedy Informatics, the leading provider of registries and research informatics software for Life Science and Translational Research and Healthcare, today announced the Princess Margaret Cancer Centre at University Health Network in Toronto has selected ComprehensiveBMT and Investigate Cell Therapy, two of Remedy's innovative clinical informatics solutions.

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

"The Princess Margaret is one of the largest comprehensive cancer facilities in the world with the largest Blood and Marrow Transplant program in Canada and a gold standard cancer research facility," said Gary Kennedy , Founder and CEO of Remedy Informatics. "Both InvestigateCT and ComprehensiveBMT offer unmatched integration of information to improve treatment outcomes by aggregating, mapping, harmonizing and analyzing data across clinical and scientific disciplines. Valuable information will give valuable insights into patient safety, patient survivorship, and quality improvement for transplant physicians, nurses and researchers."

Built on Remedy's flagship Mosaic Platform, InvestigateCT and ComprehensiveBMT offer the Princess Margaret the world's first and only truly integrated research management system. In addition to combining blood and marrow registries with cell therapy laboratories and biobanks, clinicians and researchers will have an unprecedented view of their data through the Mosaic Ontology, which aggregates, maps and harmonizes the data to facilitate pattern recognition. Together researchers are able to manage and aggregate more data sources, across disciplines, including next-generation sequencing, cross-disease registries, LIMS and the Blood and Marrow Transplant Program to advance research of cell therapies, blood and marrow transplantation, and related diseases.

"The future of patient care and innovative research in blood and marrow transplantation requires rapid data analysis to track and improve patient outcomes. We are confident Remedy Informatics can meet our needs," said Dr. John Kuruvilla , MD, FRCP(C), director, Clinical Program, Blood and Marrow Transplant program at the Princess Margaret . "We foresee better information management as the cornerstone for improving patient outcomes in hematologic malignancies."

The Princess Margaret BMT program has an international reputation as a global leader in clinical and research programs and as a gold standard in transplant technologies like Apheresis collections for peripheral stem cell transplant infusions and Extracorporeal Photopheresis for selected graft-vs-host conditions. Over the next year, Remedy will work with the Princess Margaret BMT program to implement InvestigateCT, the world's first Integrated Research Management System designed for cancer centers involved in clinical research using cell therapies. InvestigateCT will facilitate multi-directional data flow throughout the BMT program, cell therapy labs and biobanks to improve real-time analytics, therapies, patient safety, and quality across the transplant care pathway as well as long-term patient survivorship for patients who are living longer and healthier lives.

Remedy serves a wide range of leading Life Science and Translational Research institutions across the country, including the Huntsman Cancer Institute at the University of Utah, Cleveland Clinic's Bariatric and Metabolic Institute and Heart and Vascular Institute, the American Joint Replacement Registry, Baylor Health Care System, and many more.

For more information about Investigate Cell Therapy or ComprehensiveBMT, or Remedy's leading patient registry technology, please visit our website, http://www.remedyinformatics.com. InvestigateCT is for research use only and is not intended for clinical or cell processing purposes.

About Remedy Informatics, Inc.

Original post:
The Princess Margaret BMT Program Chooses Remedy Informatics' Blood and Marrow Transplant & Cell Therapy Solutions to ...

stem cell therapy @ kapuso jessica soho
LAMININE It #39;s not often that the perfect super-supplement with the perfect story comes around, but the story of Laminine is far from a mythical tale. As far back as 1929, a Medical Doctor in Canada discovered a way to extract the #39;life-essence #39; of a nine day old fertilized avian egg. Through research, it was found that on exactly the ninth day, all the ingredients necessary to create life are at its #39; highest level. In fact, the life-giving proteins are so potent at this stage that a live chick is hatched a mere two weeks thereafter. This method of extraction and freeze-drying processes proved to be a historical monumental success for this Medical Doctor #39;s patients. 09333737867 for infoFrom:xpalfredViews:1 1ratingsTime:12:00More inHowto Style

See the article here:
stem cell therapy @ kapuso jessica soho - Video

CombiCult® Workflow
A overview on how Plasticell (www.plasticell.co.uk) uses combinatorial cell culture (CombiCult®) to discover optimised stem cell differentiation protocols in record time, at a fraction of the cost of the status quo while reducing project return risk. CombiCult® is used by our customers in a range of applications in regenerative medicine, cell therapy and research and development.From:PlasticellLimitedViews:1 0ratingsTime:06:40More inScience Technology

Read more here:
CombiCult® Workflow - Video

NEW YORK (AP) Shares of biotechnology company Pluristem Therapeutics Inc. bounced back Friday after the company responded to a report that a patient treated with its PLX stem cell therapy had died.

THE SPARK: Bloomberg BusinessWeek reported Thursday that Pluristem did not disclose the death of a young patient who had been treated with its placental cell therapy before a $32 million public stock sale in September. Shares of Pluristem fell 23 percent Thursday.

The Israeli company said Thursday evening that parts of the article were inaccurate or misleading. It said the patient, a Romanian girl whose name has not been disclosed, was "in imminent danger of death" at the time she was treated with the stem cells. She was not part of an organized clinical trial and was treated on a compassionate basis because no therapy options remained.

Pluristem said the patient lived for six months after her treatment. She returned to Romania four months before she died and the company was not monitoring her health. Pluristem said it was not aware of her death at the time it sold the additional stock. Bloomberg said the patient died Sept. 12, the day the stock sale was announced. The sale closed a week later.

"The formal report relating to the death clearly stated that there was no connection between the PLX cell treatment and the death of the patient," Pluristem said in a press release.

THE BIG PICTURE: Pluristem said that three patients have been treated with PLX on a compassionate basis including the Romanian girl and two have died. The company said it believes the patients lived longer than expected following treatment, which demonstrates that PLX therapy can be effective. The company is studying the stem cells as a treatment for peripheral artery disease, nerve pain, and other conditions.

THE STOCK: Shares of Pluristem rose 39 cents, or 13.7 percent, to $3.24 on Friday. The stock reached an annual high of $5 per share in August, and including Friday's gains, the shares are down 29 percent since the company announced the stock offering.

Go here to see the original:
Pluristem shares bounce back after Thursday plunge

PRP Vs Stem Cell Therapy
PRP Therapy Vs Stem Cell TherapyFrom:MiamiFootSurgeryViews:5 0ratingsTime:01:23More inHowto Style

View original post here:
PRP Vs Stem Cell Therapy - Video

PURTIER Live Stem Cell Therapy - 4th Edition (English Version).mp4
PURTIER Live Stem Cell Therapy - 4th Edition (English Version) Please contact Pearly @ +65 9338 9541 for more detailsFrom:PurtierPearlyViews:3 0ratingsTime:09:00More inPeople Blogs

See the original post here:
PURTIER Live Stem Cell Therapy - 4th Edition (English Version).mp4 - Video

Washington, November 7 (ANI): Stem cell therapy improves heart function in patients who had previous heart attacks, according to researchers from the University of Louisville and Brigham and Women's Hospital.

In a Late-Breaking Clinical Trial session at the American Heart Association Scientific Sessions 2012 meeting, Roberto Bolli, M.D., of the University of Louisville and Piero Anversa, M.D., of Brigham and Women's Hospital, Boston, presented data from their groundbreaking research in the use of autologous adult stem cells with patients who had previous heart attacks.

They report that after two years, all patients receiving the stem cell therapy show improvement in heart function, with an overall 12.9 absolute unit increase in left ventricular ejection fraction (LVEF), a standard measure of heart function that shows the amount of blood ejected from the left ventricle during a heartbeat.

No adverse effects resulting from the therapy were seen. Moreover, MRIs performed on nine patients in the trial showed evidence of myocardial regeneration - new heart tissue replacing former dead tissue killed by heart attack.

"The trial shows the feasibility of isolating and expanding autologous stem cells from virtually every patient," said Bolli, who is the Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology and director of the Institute for Molecular Cardiology in the Department of Medicine at UofL.

"The results suggest that this therapy has a potent, beneficial effect on cardiac function that warrants further study," he stated.

The trial - called SCIPIO for Stem Cell Infusion in Patients with Ischemic CardiOmyopathy - was a randomized open-label trial of cardiac stem cells (CSCs) in patients who were diagnosed with heart failure following a myocardial infarction and had a LVEF of 40 percent or lower; the normal LVEF is 50 percent or higher.

The investigators harvested the CSCs, referred to as "c-kit positive" cells because they express the c-kit protein on their surface, from 33 patients during coronary artery bypass surgery. The stem cells were purified and processed in Anversa's lab in Boston so that they could multiply. Once an adequate number of stem cells was produced - about one million for each patient - Bolli's team in Louisville reintroduced them into the region of the patient's heart that had been scarred by the heart attack.

The researchers reported that in the 20 patients receiving CSCs, LVEF increased from 29 percent to 36 percent at four months following infusion. None of the 13 control patients in the trial received CSCs and this group showed, on average, no improvement.

The beneficial effect of the CSCs persisted and became progressively greater at the one- and two-year mark following infusion. At the one-year mark following infusion, LVEF increased by 8.1 percent, and at the two-year mark, by 12.9 percent.

Read more from the original source:
Stem cell therapy improves heart function 2 years after heart attack

Stem Cells Doctor in Mexico Shares his Expertise
http://www.mexicohealth.com The video shows a stem cells doctor in Mexico discussing various procedures he specializes in, which notably are multiple sclerosis, brain degenerative disorders, and eye sight rectification. This stem cell specialist has treated over forty patients using cutting edge stem cell therapies. Despite cynical attitudes from different quarters, this doctor represents the vanguard for stem cell treatments for progressively degenerative conditions. To read the transcript and to get a free quote from stem cells doctor in Mexico. Click the link above. Related Searches: Stem Cell Therapy Doctors Mexico, stem cell treatment glaucoma mexico, stem cell therapy brain disorders mexico, stem cell therapy brain injury mexico, stem cell treatment spinal cord MX,From:mexicohealthViews:3 0ratingsTime:04:05More inPeople Blogs

More:
Stem Cells Doctor in Mexico Shares his Expertise - Video

FAQ-13 of 19: How Much Stem Cell Therapy Will Be Enough Stem Cell for Me?
youtu.be This answers the #39;what do I need for ME? #39; question, and for your questions, go to bit.ly This seeks to answer the #39;what do I need for ME? #39; question, although it is a personal question not readily answerable online, so for your questions, go to bit.lyFrom:John PepperViews:0 0ratingsTime:01:28More inEducation

Continued here:
FAQ-13 of 19: How Much Stem Cell Therapy Will Be Enough Stem Cell for Me? - Video

The potential of regenerative medicine
Alan Russell: The potential of regenerative medicine http://www.youtube.com http://www.ted.com Alan Russell studies regenerative medicine -- a breakthrough way of thinking about disease and injury by helping the body to rebuild itself. He shows how engineered tissue that "speaks the body #39;s language" has helped a man regrow his lost fingertip, how stem cells can rebuild damaged heart muscle, and how cell therapy can regenerate the skin of burned soldiers. This new, low-impact medicine comes just in time, Russell says -- our aging population, with its steeply rising medical bills, will otherwise (and soon) cause a crisis in health care systems around the world. Some graphic medical imagery.From:BroadcastBCViews:6 0ratingsTime:19:30More inScience Technology

Follow this link:
The potential of regenerative medicine - Video

[RMS] C-Class Stem Cell Processing Center (SPC)
C-Type Member practice stem cell therapy with setting up C-class Stem cell Processing Center. Single platform with necessary equipments (including the ones for quality control tests) built in single space for the production of Chondron processing room, preparation room, utility room.From:SewonCellontechViews:1 0ratingsTime:00:46More inHowto Style

Read more here:
[RMS] C-Class Stem Cell Processing Center (SPC) - Video

University of Melbourne announce Stem Cells Discovery
Researchers have completed the study by using skin biopsies from patients with the rare genetic disease Friedreich Ataxia (FA). The discovery will allow for the development of new treatments for FA and related conditions such as diabetes and heart disease. For more information, see the following websites: University of Melbourne Stem Cell Laboratory: http://www.cns.unimelb.edu.au Monash Institute of Medical Research: http://www.monashinstitute.org Friedreich Ataxia Research Association: http://www.fara.org.au Friedreich Ataxia Research Alliance: http://www.curefa.org Credits Produced by Rebecca Scott Camera by Clive Banfield Editing by Rob Cross, Corporate Video Video of heart cells provided courtesy of: Duncan E Crombie. Senior Research Assistant Stem Cell Medicine, O #39;Brien Institute With thanks to: Dr. Alice Pébay Group Leader, Stem Cell Lab, Centre for Neuroscience and Dept of Pharmacology, The University of Melbourne Senior Research Fellow, O #39;Brien Institute Dr Mirella Dottori Group Leader, Stem Cell Lab. Centre for Neuroscience and Dept of Pharmacology, University of Melbourne Dr Paul Verma Senior Scientist, Head of the Reprogramming of Somatic Cells Lab, Centre for Reproduction and Development, Monash Institute of Medical Research Dr Jun Liu, Post-doc fellow Centre for Reproduction and Development, Monash Institute of Medical Research Ms Varlli Beetham, Executive Director, Friedreich #39;s Ataxia Research Association (FARA) Jessica Leung and the staff of the Stem Cell Lab, Centre for Neuroscience ...From:globotrashViews:1292 1ratingsTime:03:20More inPeople Blogs

More here:
University of Melbourne announce Stem Cells Discovery - Video

CBR: Celebrating 20 Years of Advancing Cord Blood Stem Cell Medicine
Learn more about how cord blood is changing medicine here: cordbloodregistry.com Join Cord Blood Registry, the world #39;s largest newborn stem cell bank, in celebrating two decades of offering families more medical options. Cord Blood Registry #39;s story starts in 1992 with the birth of Dr. David Harris #39; son, Alex. The storage of Alex #39;s cord blood stem cells marked the beginning, not only of Cord Blood Registry #39;s lab, but family cord blood banking itself. After 20 years, the first-ever family bank has accomplished many firsts including: bull; First to store cord tissue for families in the United States bull; First and only newborn stem cell bank to have pioneered FDA-regulated clinical trials in regenerative medicine For more than 20 years, cord blood stem cells have been used to help regenerate the blood and immune system in more than 25000 transplants worldwide. Current clinical trials are creating new opportunities to help the body heal itself. For more information on current clinical trial uses, plus the latest research and innovations, visit http://www.cordblood.comFrom:cordbloodregistryViews:228 1ratingsTime:02:55More inScience Technology

Follow this link:
CBR: Celebrating 20 Years of Advancing Cord Blood Stem Cell Medicine - Video

FAQ-8 of 19: In Stem Cell Therapy Do Stem Cells Cause Side Effects?
youtu.be The near-miraculous effects of stem cell treatments, when applied by qualified, licensed medical practitioners, is even more wonderful precisely because there are almost no known ill effects or side effects. So for more detailed and personalized information, go to StemCell-Asia.info to learn more on the Apply Now page httpFrom:VeteransRecallViews:0 0ratingsTime:00:53More inPeople Blogs

Read more from the original source:
FAQ-8 of 19: In Stem Cell Therapy Do Stem Cells Cause Side Effects? - Video

FAQ-8 of 19: With Stem Cell Therapy Are There Any Stem Cell Side Effects?
youtu.be The near-miraculous effects of stem cell treatments, when applied by qualified, licensed medical practitioners, is even more wonderful precisely because there are almost no known ill effects or side effects. So for more detailed and personalized information, go to StemCell-Asia.info to learn more on the Apply Now page httpFrom:John PepperViews:0 0ratingsTime:00:53More inPeople Blogs

Read the original:
FAQ-8 of 19: With Stem Cell Therapy Are There Any Stem Cell Side Effects? - Video

FAQ-7 of 19: With Stem Cell Therapy, How Long Do Stem Cell Benefits Last?
youtu.be Briefly explaining how long the benefits of stem cell therapy last, when, why and for what conditions. For more detailed explanations, go to StemCell-Asia.info and find the #39;Apply Now #39; page, httpFrom:Karridine1Views:0 0ratingsTime:01:19More inPeople Blogs

See more here:
FAQ-7 of 19: With Stem Cell Therapy, How Long Do Stem Cell Benefits Last? - Video

Doctors and researchers have long said that stem cell therapy has the potential to change the face of human disease. But what if stem cells could be used to reverse the aging process as well?

Plastic surgeons say they can use stem cells to make women look years younger without the pain of an invasive surgery.

"I lost weight, loss of volume in face, I looked gaunt and I said, so I said, 'okay what do we do to fix this?'" said Sarah, a patient.

The fix for this was a stem-cell face lift. Dr. Steve Szczerba of Chicago Aesthetic Surgery Institute recommended that Sarah undergo a procedure, where he'd use her own adult stem cells to turn back the clock.

"A stem cell facelift is rejuvenating the face using grafted fat. Grafted fat has stem cells in it," Dr. Szczerba explains.

Grafted fat is transferred fat. Dr. Szczerba typically gets it from the patient's abdomen or inner thigh during liposuction.

"During that process of liposuction, we save the fat and take the fat and prepare it for grafting by removing the fluid. And the stem cells along with other grafted fat cells are injected into the face," says Dr. Szczerba.

He says it's not simply a fat transfer. Dr. Szcerba believes the stem cells, which are specialized cells that self renew, are actually working to make collagen and rejuvenate the skin.

"You can actually see the surface of the skin change," says the doctor. "Similar to that a chemical peel or a laser peel accomplishes in order to see change in your cheek area."

Click for more from My Fox Chicago.

Follow this link:
Stem cell face lift: Does it work?